Notice to Long-Term Shareholders of ASP Isotopes Inc. (NASDAQ: ASPI); Integer Holdings Corp. (NYSE: ITGR); Molina Healthcare, Inc. (NYSE: MOH); and Soleno Therapeutics, Inc. (NASDAQ: SLNO): Grabar Law Office Investigates Claims on Your Behalf

Grabar Law Office is investigating securities fraud claims against four companies: ASP Isotopes for allegedly making false statements about uranium enrichment technology; Integer Holdings for overstating competitive position and concealing sales deterioration; Molina Healthcare for failing to disclose adverse medical cost trends; and Soleno Therapeutics for misrepresenting the safety profile of its drug candidate DCCR, which resulted in a patient death.

03/20/2026, 9:41 AM • GlobeNewswire

Important Notice to Long-Term Shareholders of ASP Isotopes Inc. (NASDAQ: ASPI); Integer Holdings Corp. (NYSE: ITGR): Soleno Therapeutics, Inc. (NASDAQ: SLNO); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office is Investigating Claims on Your Behalf

Grabar Law Office is investigating securities fraud claims against four companies: ASP Isotopes for allegedly making false statements about uranium enrichment technology; Integer Holdings for overstating competitive position and concealing sales deterioration; Soleno Therapeutics for misrepresenting safety profile of drug candidate DCCR/VYKAT XR; and Unicycive Therapeutics for overstating FDA manufacturing compliance readiness. Shareholders who purchased shares during specified periods may be eligible to seek corporate reforms and compensation.

03/18/2026, 9:17 AM • GlobeNewswire

Notice to Long-Term Shareholders of ASP Isotopes Inc. (NASDAQ: ASPI); Camping World Holdings, Inc. (NYSE: CWH); EOS Energy Enterprise, Inc. (NASDAQ: EOSE); and Soleno Therapeutics, Inc. (NASDAQ: SLNO): Grabar Law Office Investigates Claims on Your Behalf

Grabar Law Office is investigating securities fraud claims against four companies: ASP Isotopes (ASPI) for allegedly making false statements about uranium enrichment technology; Camping World (CWH) for misrepresenting inventory management and financial outlook; EOS Energy (EOSE) for failing to disclose production challenges and operational issues; and Soleno Therapeutics (SLNO) for concealing safety concerns about its drug candidate DCCR/VYKAT XR. Long-term shareholders may seek corporate reforms and compensation at no cost.

03/14/2026, 12:29 PM • GlobeNewswire

Shorepower Technologies (OTC: SPEV) Enters Merger Agreement with Aeternum Health LLC and Announces Strategic Transition to Longevity-Focused Healthcare Platform

Shorepower Technologies (OTC: SPEV) has entered into a merger agreement with Aeternum Health LLC, marking a strategic pivot from transportation electrification infrastructure to longevity and health optimization technologies. The merger involves issuing 51% common stock ownership to Aeternum Health's sole member, 2 million Series B Preferred Shares, and a minimum $1.5 million cash contribution. Paul E. Mann, CEO of ASP Isotopes (NASDAQ: ASPI), will become the new CEO of Shorepower upon closing. The company plans to spin out its existing transportation electrification business and change its corporate name to Aeternum Health Inc.

02/24/2026, 8:30 AM • Benzinga

ASP Isotopes Closes Acquisition of Renergen

ASP Isotopes (NASDAQ:ASPI) has successfully closed its acquisition of Renergen Limited, creating a combined company focused on critical isotopes and helium production. The deal integrates ASP Isotopes' enrichment technologies with Renergen's helium and natural gas operations. Renergen's Virginia Gas Project has secured $40 million in U.S. government funding and is expected to receive an additional $750 million in committed debt funding from the U.S. DFC and Standard Bank to expand production capacity. The combined company targets applications in semiconductors, quantum computing, and clean energy sectors.

01/07/2026, 8:30 AM • Benzinga

ASP Isotopes Inc. Announces Receipt of Regulatory Approvals for Acquisition of Renergen Limited

ASP Isotopes has received all required regulatory approvals to acquire Renergen Limited, a South African company focused on liquefied helium and natural gas production. The acquisition aims to create a global leader in critical materials production with expected synergies from 2026.

12/17/2025, 9:30 AM • Benzinga

ASP Isotopes Announces Quantum Leap Energy's Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering

ASP Isotopes' subsidiary Quantum Leap Energy has confidentially submitted a draft registration statement to the SEC for an initial public offering of its Class A common stock, with details of share count and pricing yet to be determined.

11/12/2025, 5:17 PM • Benzinga

ASP Isotopes Inc. Hosts South African Investors in Advance of Secondary Listing on the Johannesburg Stock Exchange (JSE) and Provides Updates on its Isotope Production Plants

ASP Isotopes is preparing for a secondary listing on the Johannesburg Stock Exchange, hosting South African investors and providing updates on its isotope production facilities in Pretoria, including progress on Silicon-28, Ytterbium-176, and Carbon-12 enrichment projects.

08/26/2025, 8:00 AM • GlobeNewswire